Výsledky vyhledávání - "Jeffrey Samuel Co"

Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis

Autor: Ting-Lung Lin, Yu-Chen Wang, Domelle Dave Encarnacion, Jeffrey Samuel Co, Chih-Che Lin, Chao-Chien Wu, Yi-Chia Chan, Wei-Feng Lee, Chao-Long Chen, Noruel Gerard A Salvador

Publikováno v: Biomedical Journal. 44:S162-S170

Background The Interaction between anti-tuberculous and immunosuppressive drugs which may increase the risk of graft rejections is a major challenge in managing transplant recipients with tuberculosis (TB). Instead of rifampicin (RFM), most guideline

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da316da9bb72efacfa5a0bb17a6797c
https://doi.org/10.1016/j.bj.2020.08.010

Zobrazit plný text záznamu

Staged ligation of large portosystemic collaterals in living donor liver transplantation using a small-for-size graft

Autor: Jeffrey Samuel Co, Chih-Yi Chen, Chih-Che Lin, Aldwin D. Ong, Chao-Long Chen, Chee-Chien Yong, Yu-Fan Cheng

Publikováno v: Hepatobiliary Surg Nutr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389b805f6b9c8a51e6da144a6eaf9ccc
https://doi.org/10.21037/hbsn-20-330

Zobrazit plný text záznamu

Optimizing biliary outcomes in living donor liver transplantation: Evolution towards standardization in a high-volume center

Autor: Jeffrey Samuel Co, Aldwin D. Ong, Tsan-Shiun Lin, Chao-Long Chen

Publikováno v: Hepatobiliarypancreatic diseases international : HBPD INT. 19(4)

Biliary complications have always been a dreaded cause of morbidity after living donor liver transplantation. While intrinsic variations in both graft and recipient biliary anatomy remain a significant factor to the difficulty of biliary reconstructi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef43b6cb09e0775ef9f09a37e44b0638
https://pubmed.ncbi.nlm.nih.gov/32631761

Zobrazit plný text záznamu

A Proposed Predictive Model for Hyperperfusion Syndrome After Living Donor Liver Transplantation Using Platelet Count and Portal Vein Flow as Surrogates for Portal Pressure Measurement

Autor: Chih-Chi Wang, Jeffrey Samuel Co, Chih-Che Lin, Chao-Long Chen, Chee-Chien Yong

Publikováno v: HPB. 23:S416-S417

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7a559c700d31903fb01c7e3b957af48
https://doi.org/10.1016/j.hpb.2020.11.1075

Zobrazit plný text záznamu

IDDF2019-ABS-0347 Platelet count after living donor liver transplantation as a surrogate for portal vein pressure monitoring and predictor of graft hyperperfusion syndrome: the ‘5–67–8’ rule

Autor: Chee-Chien Yong, Chih-Chi Wang, Chih-Che Lin, Jeffrey Samuel Co

Publikováno v: Gut – IDDF Young Investigator Award.

Background Thrombocytopenia early after living donor liver transplantation (LDLT) mainly occurs secondary to hepatic/splenic sequestration, a product of Portal vein pressure (PVP). Portal vein flow (PVF) unlike PVP, is mainly an inflow parameter and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d07c8cdf3945d7fdeddd8d631d66aec0
https://doi.org/10.1136/gutjnl-2019-iddfabstracts.16

Zobrazit plný text záznamu